# Miglustat

NDC: 70710-2039
Generic name: Miglustat
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250401

FDA application: ANDA219111

## Active ingredients

- MIGLUSTAT: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-2039"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-2039
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b54cc8a0-2284-44c3-a8fa-d8aaa87a67c6